image description

Executive Briefing

Two page monthly briefing that provides 1-2 paragraph synopses of recent Institute research, news items of interest or concern, or action items for principal execs.

The Costliest Opioid in Calif WC . . . WCIRB Reports Insurer Experience Through Q4 2022 . . . CWCI Releases 2023 Case Law Seminar as an On-Demand Webinar . . . IMR Update: CWCI Reports on Results Through 2022 and Factors That Drive IMR Outcomes and Volume . . . Member...

image description

Quarterly Summary

One to two line descriptions of various issues covered in CWCI publications over the latest quarter. Listings specify the type of publications produced and links to the items on the CWCI website.

image description

Technical Issues

One to two page summaries usually on a technical or regulatory issue that may require action by our members.

CDI Issues WC Adjuster Certification Data Call For 2023

image description


One to two page summaries on topics of note to CWCI members and members of the workers' compensation community. Bulletins cover CWCI research and other issues including regulations and legislation, industry trends,...

Cost-Driver Medications in the Top California Workers' Comp Drug Groups: Part 2, Dermatologicals, Opioids, and Antidepressants

A CWCI analysis identifying nine Dermatologicals, Opioids, and Antidepressants that consume a disproportionate share of the total payments within their therapeutic drug groups relative to their share of the...